SPC
TGTX icon

Sigma Planning Corp’s TG Therapeutics TGTX Stock Holding History

Sigma Planning Corp’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Buy
+15,375
New +$629K 0.02% 673
2025
Q3 		– Sell
-35,227
Closed -$1.27M – 1376
2025
Q2 		$1.27M Buy
35,227
+3,472
+11% +$129K 0.04% 426
2025
Q1 		$1.25M Buy
+31,755
New +$1.07M 0.04% 410

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Sigma Planning Corp's TGTX Position: Q2 2026 in Review

Sigma Planning Corp opened a new position in TG Therapeutics (TGTX) in Q2 2026: 15,375 shares worth $845K. The stake represents 0.02% of the portfolio and ranks #673 among its holdings. This is a return to the name: Sigma Planning Corp previously reported a position in TGTX as recently as Q2 2025.

Sigma Planning Corp first reported a position in TGTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.27M in Q2 2025. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Sigma Planning Corp held 15,375 shares of TG Therapeutics worth $845K as of Q2 2026.
  • TG Therapeutics was a new Sigma Planning Corp position in Q2 2026.
  • TG Therapeutics made up 0.02% of Sigma Planning Corp's portfolio in Q2 2026, its #673 holding.
  • Sigma Planning Corp first reported a position in TG Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Sigma Planning Corp's TG Therapeutics position peaked at $1.27M in Q2 2025.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.